Lantern Pharma Inc. (LTRN) stock
LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.24−0.04 (-13.70%)
Close on Nov 20, 2026Market cap $3.13MP/E –Yield –
Lantern Pharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Lantern Pharma's shares outstanding was 14M at Sep 30, 2026. For fiscal 2025 it was 11M, up 1.3% from the year before. The highest annual figure on record is 11M in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11M | +1.3% |
| FY2024 | Dec 31, 2024 | 11M | -0.7% |
| FY2023 | Dec 31, 2023 | 11M | -0.1% |
| FY2022 | Dec 31, 2022 | 11M | -0.5% |
| FY2021 | Dec 31, 2021 | 11M | +153.3% |
| FY2020 | Dec 31, 2020 | 4M | +117.6% |
| FY2019 | Dec 31, 2019 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 14M | +25.8% |
| Q2 FY2026 | Jun 30, 2026 | 12M | +15.2% |
| Q1 FY2026 | Mar 31, 2026 | 11M | +4.3% |
| Q4 FY2025 | Dec 31, 2025 | 11M | +3.8% |
| Q3 FY2025 | Sep 30, 2025 | 11M | +0.7% |
| Q2 FY2025 | Jun 30, 2025 | 11M | +0.2% |
| Q1 FY2025 | Mar 31, 2025 | 11M | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | 11M | -0.1% |
| Q3 FY2024 | Sep 30, 2024 | 11M | -0.9% |
| Q2 FY2024 | Jun 30, 2024 | 11M | -0.9% |
| Q1 FY2024 | Mar 31, 2024 | 11M | -1.1% |
| Q4 FY2023 | Dec 31, 2023 | 11M | -0.5% |
| Q3 FY2023 | Sep 30, 2023 | 11M | +0.2% |
| Q2 FY2023 | Jun 30, 2023 | 11M | +0.2% |
| Q1 FY2023 | Mar 31, 2023 | 11M | -0.2% |
| Q4 FY2022 | Dec 31, 2022 | 11M | -2.8% |
| Q3 FY2022 | Sep 30, 2022 | 11M | -3.1% |
| Q2 FY2022 | Jun 30, 2022 | 11M | -3.1% |
| Q1 FY2022 | Mar 31, 2022 | 11M | +8.0% |
| Q4 FY2021 | Dec 31, 2021 | 11M | +79.1% |
| Q3 FY2021 | Sep 30, 2021 | 11M | +79.9% |
| Q2 FY2021 | Jun 30, 2021 | 11M | +311.2% |
| Q1 FY2021 | Mar 31, 2021 | 10M | +398.5% |
| Q4 FY2020 | Dec 31, 2020 | 6M | +215.1% |
| Q3 FY2020 | Sep 30, 2020 | 6M | +214.3% |
| Q2 FY2020 | Jun 30, 2020 | 3M | +37.5% |
| Q1 FY2020 | Mar 31, 2020 | 2M | – |
| Q4 FY2019 | Dec 31, 2019 | 2M | – |
| Q3 FY2019 | Sep 30, 2019 | 2M | – |
| Q2 FY2019 | Jun 30, 2019 | 2M | – |
See a number that looks wrong?